Eko Company
.png)
Eko develops FDA approved, AI-powered heart sound and EKG sensors for heart disease monitoring.
Last Funding Type:
Series C
Last Funding Date:
2020
Funding Status:
Late Stage Venture
Headquarters:
San Francisco Bay Area, West Coast, Western US
Industry:
Artificial Intelligence, Health Care, Health Diagnostics, Machine Learning, Medical Device, Software, mHealth
Investor Type:
Late Stage Venture
Estimated Revenue:
$1M to $10M
Technology:
Digital Healthcare
Total Funding:
95500000
Investors Number:
22
Employee Number:
11-50
Founded Date:
2013-01-01